Robert Thomas Dechant - 09 Nov 2026 Form 4 Insider Report for IBEX Ltd (IBEX)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: IBEX
Reported as of: 09 Nov 2026
Net transaction value: -$250,031
SEC form: 4
Accepted by SEC: 10 Nov 2026, 17:13:19 UTC
Prior SEC filing: 03 Nov 2026
Source filing: View source filing
Reporting owner signature: Lisa Lenstrohm, Attorney-in-Fact

Filing notes and source

Key filing fact

Robert Thomas Dechant filed Form 4 for IBEX Ltd (IBEX) on 10 Nov 2026.

Key facts

This page summarizes Robert Thomas Dechant's Form 4 filing for IBEX Ltd (IBEX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 10 Nov 2026, 17:13.

Change

Previous filing in this sequence was filed on 03 Nov 2026.
Current net transaction value: -$250,031.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001298255 Primary reporting owner

Dechant Robert Thomas

Relationship: Chief Executive Officer, Director
Address: C/O IBEX LIMITED, 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON
Signature: Lisa Lenstrohm, Attorney-in-Fact
Signature date: 10 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IBEX transaction

Common Shares

Sale

Transaction value: -$250,031
Shares: -5,000
Change %: -1.7%
Price: $50.01
Shares after: 297,448
Date: 09 Nov 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Sales made pursuant to the Reporting Person's 10b5-1 Plan dated November 18, 2025.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $50.00 to $50.14; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.